Costs of cardiovascular and renal complications in type 2 diabetes by stage of disease

被引：0
|
作者：
Brown, JB
Pedula, KL
Glauber, HS
Bakst, AW
机构：
[1] Kaiser Permanente NW, Portland, OR USA
[2] SmithKline Beecham Pharmaceut, Collegeville, PA USA
来源：
DIABETOLOGIA | 1998年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
982
引用
收藏
页码：A254 / A254
页数：1
相关论文
共 50 条
  • [31] Epidemiology of cardiovascular complications in type 2 diabetes mellitus
    Meigs, JB
    ACTA DIABETOLOGICA, 2003, 40 (Suppl 2) : S358 - S361
  • [32] Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database
    Luk, Andrea O. Y.
    Hui, Eric M. T.
    Sin, Ming-Chuen
    Yeung, Chun-Yip
    Chow, Wing-Sun
    Ho, Andrew Y. Y.
    Hung, Hin-Fai
    Kan, Eva
    Ng, Chiu-Ming
    So, Wing-Yee
    Yeung, Chi-Kin
    Chan, Kin-Sang
    Chan, Kin-Wah
    Chan, Pang-Fai
    Siu, Shing-Chung
    Tiu, Sau-Cheung
    Yeung, Vincent T. F.
    Chan, Juliana C. N.
    Chan, Frank W. K.
    Cheung, Clement
    Cheung, Ngai-Tseung
    Ho, Siu-Tung
    Lam, Karen S. L.
    Yu, Linda W. L.
    Chao, David
    Lau, Ip-Tim
    DIABETES CARE, 2017, 40 (07) : 928 - 935
  • [33] Cardiovascular complications of renal disease
    Jardine, AG
    McLaughlin, K
    HEART, 2001, 86 (04) : 459 - 466
  • [34] Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
    Sara J. Jenks
    Bryan R. Conway
    Stela McLachlan
    Wei Leng Teoh
    Rachel M. Williamson
    David J. Webb
    Paul Welsh
    Naveed Sattar
    Mark W. J. Strachan
    Jackie F. Price
    Diabetologia, 2017, 60 : 1400 - 1408
  • [35] Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
    Jenks, Sara J.
    Conway, Bryan R.
    McLachlan, Stela
    Teoh, Wei Leng
    Williamson, Rachel M.
    Webb, David J.
    Welsh, Paul
    Sattar, Naveed
    Strachan, Mark W. J.
    Price, Jackie F.
    DIABETOLOGIA, 2017, 60 (08) : 1400 - 1408
  • [36] Therapeutic Use of Oxytocin on the RAGE Complex in Cardiovascular and Renal Complications of Type 1 and 2 Diabetes
    Yip, Denis
    Plante, Eric
    Danalache, Bogdan
    Jankowski, Marek
    Gutkowska, Jolanta
    Menaouar, Ahmed
    DIABETES, 2014, 63 : A117 - A117
  • [37] Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil
    Sesso, Ricardo
    da Silva, Camilla Barbosa
    Kowalski, Sergio C.
    Manfredi, Silvia R.
    Canziani, Maria E.
    Draibe, Sergio A.
    Elgazzar, Heba A.
    Ferraz, Marcos B.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 126 - 130
  • [38] Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001
    Sandoz, MS
    Ess, SM
    Keusch, GW
    Schwenkglenks, M
    Szucs, TD
    SWISS MEDICAL WEEKLY, 2004, 134 (31-32) : 448 - 458
  • [39] Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy
    Alexander, CM
    Lyle, PA
    Keane, WF
    Carides, GW
    Zhang, ZX
    Shahinfar, S
    KIDNEY INTERNATIONAL, 2004, 66 : S115 - S117
  • [40] Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
    Jae-Seung Yun
    Yong-Moon Park
    Kyungdo Han
    Hyung-Wook Kim
    Seon-Ah Cha
    Yu-Bae Ahn
    Seung-Hyun Ko
    Scientific Reports, 11
12345